Document is current

Any future updates will be listed below

Does “OPTINAB” strategy (“stop-and-go”) work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel–gemcitabine?

Crossref DOI link: https://doi.org/10.1007/s00280-017-3374-x

Published Online: 2017-06-29

Published Print: 2017-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark